Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FASL antibody (AA 107-222)

This anti-FASL antibody is a Mouse Monoclonal antibody detecting FASL in IHC (f). Suitable for Human.
Catalog No. ABIN7126570

Quick Overview for FASL antibody (AA 107-222) (ABIN7126570)

Target

See all FASL Antibodies
FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))

Reactivity

  • 109
  • 43
  • 31
  • 20
  • 6
  • 4
  • 4
  • 2
  • 1
Human

Host

  • 84
  • 29
  • 10
  • 5
  • 3
  • 1
Mouse

Clonality

  • 92
  • 40
Monoclonal

Conjugate

  • 75
  • 13
  • 10
  • 7
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FASL antibody is un-conjugated

Application

  • 85
  • 53
  • 33
  • 28
  • 28
  • 25
  • 13
  • 13
  • 10
  • 8
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 16
    • 13
    • 8
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 107-222

    Specificity

    Cytotoxic T lymphocyte (CTL)-mediated cytotoxicity constitutes an important component of specific effector mechanisms in immuno-surveillance against virus-infected or transformed cells. Two mechanisms appear to account for this activity, one of which is the perforin-based process. Independently, a FAS-based mechanism involves the transducing molecule FAS (also designated Apo-1) and its ligand (FAS-L). The human FAS protein is a cell surface glycoprotein that belongs to a family of receptors that includes CD40, nerve growth factor receptors and tumor necrosis factor receptors. The FAS antigen is expressed on a broad range of lymphoid cell lines, certain of which undergo apoptosis in response to treatment with antibody to FAS. These findings strongly imply that targeted cell death is potentially mediated by the intercellular interactions of FAS with its ligand or effectors, and that FAS may be critically involved in CTL-mediated cytotoxicity.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Human recombinant FASLG protein fragment (around aa 107-222) (exact sequence is proprietary)

    Isotype

    IgG1
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil or prostate.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))

    Alternative Name

    FASLG

    Background

    ALPS1B, Apoptosis (APO 1) antigen ligand 1, APT1LG1, CD178 antigen, CD95 ligand protein, Generalized lymphoproliferative disease (Gld), soluble form, Tumor necrosis factor ligand superfamily member 6 (TNFL6 / TNFSF6),Fas Ligand (FASLG)
    Cellular localisation: Cell surface. Secreted.

    Molecular Weight

    26kDa (soluble FAS-L) / 40kDa (FAS-L membrane)

    Gene ID

    356, 2007

    UniProt

    P48023

    Pathways

    Apoptosis, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!